News Briefs

Neuro23 takes in $100m Series C

Neuron23 Inc., a developer of precision medicines, has secured $100 million in Series C financing.

30 March 2022

Neuron23 Inc., a developer of precision medicines, has secured $100 million in Series C financing. SoftBank Vision Fund 2 led the round.

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Register now